Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vTv Therapeutics
vTv Therapeutics
Small biotech CEO exodus continues as vTv, a troubled former Alzheimer's player, sees chief leave after just 4 months
Endpoints
Fri, 03/4/22 - 10:09 am
biotech
vTv Therapeutics
Alzheimer's disease
vTv Therapeutics lays off 65% of its workforce two months after leadership change
Bizjournals
Wed, 12/8/21 - 10:46 am
layoffs
restructuring
vTv Therapeutics
type 1 diabetes
FDA Grants vTv’s Type 1 Diabetes Drug Breakthrough Therapy Designation
BioSpace
Tue, 04/13/21 - 10:01 pm
vTv Therapeutics
TTP399
type 1 diabetes
breakthrough therapies
FDA
Second Shot at Alzheimer's Proves Unsuccessful for vTv Therapeutics' Azeliragon
BioSpace
Wed, 12/16/20 - 11:27 am
vTv Therapeutics
azeliragon
Alzheimer's disease
VTV celebrates a double positive
EP Vantage
Wed, 02/12/20 - 10:29 am
vTv Therapeutics
Alzheimer's disease
diabetes
azeliragon
clinical trials
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
CP Wire
Thu, 05/31/18 - 09:40 am
vTv Therapeutics
COPD
PDE4 inhibitors
vTv Therapeutics Announces Deal in Asia for its PDE4 Inhibitor
Thu, 05/31/18 - 09:39 am
vTv Therapeutics
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study
CP Wire
Mon, 04/9/18 - 09:26 pm
vTv Therapeutics
azeliragon
Alzheimer's disease
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study
Mon, 04/9/18 - 08:21 pm
vTv Therapeutics
azeliragon
Alzheimer's disease
Another Alzheimer's IPO
Seeking Alpha
Fri, 07/31/15 - 11:12 am
Alzheimer's disease
azeliragon
vTv Therapeutics